Osaic Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Hold
1
﹤0.01% 6407
2026
Q1
$10.6K Hold
1
﹤0.01% 6253
2025
Q4
$11.6K Hold
1
﹤0.01% 6246
2025
Q3
$7.6K Hold
1
﹤0.01% 6527
2025
Q2
$12.7K Hold
1
﹤0.01% 6013
2025
Q1
$16.4K Hold
1
﹤0.01% 5489
2024
Q4
$5.6K Buy
+1
New +$464 ﹤0.01% 6129
2024
Q2
Sell
-1
Closed -$9.97K 7630
2024
Q1
$9.97K Hold
1
﹤0.01% 5741
2023
Q4
$9.4K Hold
1
﹤0.01% 5861
2023
Q3
$5.42K Hold
1
﹤0.01% 6238
2023
Q2
$6.59K Hold
1
﹤0.01% 6186
2023
Q1
$3.87K Buy
+1
New +$300 ﹤0.01% 6461
2022
Q4
Sell
-1
Closed -$6K 7445
2022
Q3
$6K Buy
+1
New +$288 ﹤0.01% 6308

Other funds holding VRTX

Osaic Holdings's VRTX Position: Q2 2026 in Review

Osaic Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, buying an estimated $2.49M and bringing the position to 49,586 shares worth $24.6M. The position accounts for 0.03% of the portfolio, ranked #591.

Osaic Holdings first reported a position in VRTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $40.4M in Q3 2023. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Osaic Holdings held 49,586 shares of Vertex Pharmaceuticals worth $24.6M as of Q2 2026.
  • Osaic Holdings bought 5,614 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.49M.
  • Vertex Pharmaceuticals made up 0.03% of Osaic Holdings's portfolio in Q2 2026, its #591 holding.
  • Osaic Holdings first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Vertex Pharmaceuticals position peaked at $40.4M in Q3 2023.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.